PFCS
ATYR

Pale Fire Capital SE’s aTyr Pharma ATYR Stock Holding History

Pale Fire Capital SE’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-91,232
Closed -$178K – 64
2024
Q1 		$178K Sell
91,232
-202,474
-69% -$353K 0.02% 35
2023
Q4 		$414K Buy
293,706
+237,849
+426% +$305K 0.06% 39
2023
Q3 		$88.3K Buy
+55,857
New +$103K 0.01% 58

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pale Fire Capital SE's ATYR Position: Q2 2024 in Review

Pale Fire Capital SE sold out of aTyr Pharma (ATYR) in Q2 2024, closing a stake of 91,232 shares — an estimated $178K sold.

Pale Fire Capital SE first reported a position in ATYR in Q3 2023 and held it in 3 quarters. The position peaked at $414K in Q4 2023. 47 funds tracked by Wall St. Rank hold ATYR as of Q2 2024.

  • Pale Fire Capital SE reported no remaining aTyr Pharma position as of Q2 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 91,232 aTyr Pharma shares in Q2 2024, an estimated $178K.
  • Pale Fire Capital SE first reported a position in aTyr Pharma in Q3 2023 and held it in 3 quarters.
  • Pale Fire Capital SE's aTyr Pharma position peaked at $414K in Q4 2023.
  • 47 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2024.

Based on Pale Fire Capital SE's 13F filing for Q2 2024, filed 13 Aug 2024.